| Year |
Citation |
Score |
| 2012 |
Chen Q, Cichon J, Wang W, Qiu L, Lee SJ, Campbell NR, Destefino N, Goard MJ, Fu Z, Yasuda R, Looger LL, Arenkiel BR, Gan WB, Feng G. Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron. 76: 297-308. PMID 23083733 DOI: 10.1016/J.Neuron.2012.07.011 |
0.442 |
|
| 2011 |
Campbell NR, Fernandes CC, John D, Lozada AF, Berg DK. Nicotinic control of adult-born neuron fate. Biochemical Pharmacology. 82: 820-7. PMID 21723854 DOI: 10.1016/J.Bcp.2011.06.021 |
0.711 |
|
| 2010 |
Campbell NR, Fernandes CC, Halff AW, Berg DK. Endogenous signaling through alpha7-containing nicotinic receptors promotes maturation and integration of adult-born neurons in the hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8734-44. PMID 20592195 DOI: 10.1523/Jneurosci.0931-10.2010 |
0.35 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Chang I, Muralidharan KK, Campbell N, Ho PR. Modeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every-4-Week Dosing to Extended-Interval Dosing. Journal of Clinical Pharmacology. PMID 32949472 DOI: 10.1002/Jcph.1737 |
0.277 |
|
| 2019 |
Kappos L, Butzkueven H, Spelman T, Trojano M, Wiendl H, Jiang X, Kasliwal R, Campbell N, Ho P, Licata S. Real-world data from over 10 years in the TYSABRI® Observational Program: Long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients Revue Neurologique. 175. DOI: 10.1016/J.Neurol.2019.01.271 |
0.272 |
|
| 2020 |
Butzkueven H, Kappos L, Spelman T, Trojano M, Wiendl H, Su R, Hyde R, Licata S, Ho PR, Campbell N. Revue Neurologique. 176: S124. PMID 32906292 DOI: 10.1016/J.Neurol.2020.01.341 |
0.263 |
|
| 2018 |
Butzkueven H, Jeffery D, Arnold DL, Filippi M, Geurts JJ, Dong Q, Campbell N, Licata S, Ho P. 086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Anzan.85 |
0.263 |
|
| 2018 |
Ryerson LZ, Foley J, Chang I, Kister I, Cutter G, Metzger R, Goldberg JD, Li X, Riddle E, Smirnakis K, Yu B, Ren Z, Hotermans C, Ho P, Campbell N. 071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch® prescribing program Journal of Neurology, Neurosurgery & Psychiatry. 89: A29.2-A29. DOI: 10.1136/Jnnp-2018-Anzan.70 |
0.261 |
|
| 2018 |
Butzkueven H, Kappos L, Spelman T, Trojano M, Wiendl H, Dong Q, Licata S, Ho P, Campbell N. 085 Clinical outcomes were better for relapsing-remitting multiple sclerosis (RRMS) patients who remained on natalizumab compared to those who switched to oral or injectable therapies after 2 years in the tysabri® observational program (TOP) Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Anzan.84 |
0.256 |
|
| 2020 |
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S. Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP). Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32234967 DOI: 10.1136/Jnnp-2019-322326 |
0.254 |
|
| 2019 |
Zhovtis RL, Foley J, Chang I, Kister I, Cutter G, Metzger R, Goldberg JD, Li X, Riddle E, Smirnakis K, Yu B, Ren Z, Hotermans C, Ho P, Campbell N. Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program Revue Neurologique. 175: S102. DOI: 10.1016/J.Neurol.2019.01.272 |
0.252 |
|
| 2018 |
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, et al. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. The Lancet. Neurology. PMID 29545067 DOI: 10.1016/S1474-4422(18)30069-3 |
0.236 |
|
| 2014 |
Lublin FD, Cutter G, Giovannoni G, Pace A, Campbell NR, Belachew S. Natalizumab reduces relapse clinical severity and improves relapse recovery in MS. Multiple Sclerosis and Related Disorders. 3: 705-11. PMID 25891549 DOI: 10.1016/J.Msard.2014.08.005 |
0.234 |
|
| 2020 |
Butzkueven H, Trojano M, Kappos L, Spelman T, Wiendl H, Rosales K, Su R, Licata S, Ho PR, Campbell N. Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri Observational Program (TOP). Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520917925. PMID 32406786 DOI: 10.1177/1352458520917925 |
0.231 |
|
| 2006 |
Campbell NR, Podugu SP, Ferrari MB. Spatiotemporal characterization of short versus long duration calcium transients in embryonic muscle and their role in myofibrillogenesis. Developmental Biology. 292: 253-64. PMID 16460724 DOI: 10.1016/J.Ydbio.2005.11.040 |
0.229 |
|
| 2020 |
Wiendl H, Spelman T, Butzkueven H, Kappos L, Trojano M, Su R, Campbell N, Ho PR, Licata S. Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520926869. PMID 32579430 DOI: 10.1177/1352458520926869 |
0.224 |
|
| 2017 |
Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies. The Lancet. Neurology. PMID 28969984 DOI: 10.1016/S1474-4422(17)30282-X |
0.213 |
|
| 2020 |
Foley J, Zhovtis RL, Chang I, Ilya Kister, Cutter G, Metzger R, Riddle E, Ren Z, Hotermans C, Mason L, Ho PR, Campbell N. Revue Neurologique. 176: S125. PMID 32906294 DOI: 10.1016/J.Neurol.2020.01.343 |
0.194 |
|
| 2019 |
Ho PR, Campbell N, Chang I. The risk of PML from natalizumab - Authors' reply. The Lancet. Neurology. 18: 230-231. PMID 30784549 DOI: 10.1016/S1474-4422(19)30022-5 |
0.179 |
|
| 2022 |
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Smirnakis K, Xiao S, Kong G, Kuhelj R, Campbell N. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. The Lancet. Neurology. PMID 35483387 DOI: 10.1016/S1474-4422(22)00143-0 |
0.134 |
|
| 2021 |
Butzkueven H, Kappos L, Spelman T, Trojano M, Wiendl H, Su R, Liao S, Hyde R, Licata S, Ho PR, Campbell N. No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP). Therapeutic Advances in Neurological Disorders. 14: 17562864211042458. PMID 34603507 DOI: 10.1177/17562864211042458 |
0.114 |
|
| 2022 |
Ryerson LZ, Naismith RT, Krupp LB, Charvet LE, Liao S, Fisher E, de Moor C, Williams JR, Campbell N. No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS. Multiple Sclerosis and Related Disorders. 58: 103480. PMID 35051898 DOI: 10.1016/j.msard.2021.103480 |
0.114 |
|
| 2012 |
Gee ME, Bienek A, McAlister FA, Robitaille C, Joffres M, Tremblay MS, Johansen H, Campbell NR. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension. The Canadian Journal of Cardiology. 28: 375-82. PMID 22402028 DOI: 10.1016/J.Cjca.2011.12.012 |
0.108 |
|
| 2013 |
Quan H, Chen G, Tu K, Bartlett G, Butt DA, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, Khan N, Lix LM, Smith M, Svenson L, Walker RL, Wielgosz A, et al. Outcomes among 3.5 million newly diagnosed hypertensive Canadians. The Canadian Journal of Cardiology. 29: 592-7. PMID 23465341 DOI: 10.1016/j.cjca.2012.12.016 |
0.099 |
|
| 2011 |
Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, ... ... Campbell NR, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. The Canadian Journal of Cardiology. 27: 415-433.e1-2. PMID 21801975 DOI: 10.1016/J.Cjca.2011.03.015 |
0.097 |
|
| 2020 |
Butzkueven H, Licata S, Jeffery D, Arnold DL, Filippi M, Geurts JJ, Santra S, Campbell N, Ho PR. Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. Bmj Open. 10: e038861. PMID 33082194 DOI: 10.1136/bmjopen-2020-038861 |
0.095 |
|
| 2024 |
Butzkueven H, Kalincik T, Patti F, Slee M, Weinstock-Guttman B, Buzzard K, Skibina O, Alroughani R, Prat A, Girard M, Horakova D, Havrdova EK, Van der Walt A, Eichau S, Hyde R, ... Campbell N, et al. Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic Advances in Neurological Disorders. 17: 17562864231221331. PMID 38414723 DOI: 10.1177/17562864231221331 |
0.094 |
|
| 2019 |
Ryerson LZ, Foley J, Chang I, Kister I, Cutter G, Metzger RR, Goldberg JD, Li X, Riddle E, Smirnakis K, Kasliwal R, Ren Z, Hotermans C, Ho PR, Campbell N. Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing. Neurology. PMID 31515290 DOI: 10.1212/Wnl.0000000000008243 |
0.093 |
|
| 2012 |
Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, ... ... Campbell NR, et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. The Canadian Journal of Cardiology. 28: 270-87. PMID 22595447 DOI: 10.1016/J.Cjca.2012.02.018 |
0.09 |
|
| 2012 |
Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, Rajeshkumar NV. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Molecular Cancer Therapeutics. 11: 1999-2009. PMID 22752426 DOI: 10.1158/1535-7163.Mct-12-0017 |
0.088 |
|
| 2015 |
Campbell NR, Lackland DT, Lisheng L, Niebylski ML, Nilsson PM, Zhang XH. Using the Global Burden of Disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension League. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 165-7. PMID 25644474 DOI: 10.1111/Jch.12479 |
0.084 |
|
| 2014 |
Campbell NR, Appel LJ, Cappuccio FP, Correa-Rotter R, Hankey GJ, Lackland DT, MacGregor G, Neal B, Niebylski ML, Webster J, Willis KJ, Woodward M. A call for quality research on salt intake and health: from the World Hypertension League and supporting organizations. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 469-71. PMID 25039447 DOI: 10.1111/Jch.12364 |
0.082 |
|
| 2022 |
Beynon V, George IC, Elliott C, Arnold DL, Ke J, Chen H, Zhu L, Ke C, Giovannoni G, Scaramozza M, Campbell N, Bradley DP, Franchimont N, Gafson A, Belachew S. Chronic lesion activity and disability progression in secondary progressive multiple sclerosis. Bmj Neurology Open. 4: e000240. PMID 35720980 DOI: 10.1136/bmjno-2021-000240 |
0.081 |
|
| 2023 |
Dsilva L, McCarthy K, Lyons J, Cabigas B, Campbell N, Kong G, Adams B, Kuhelj R, Singhal P, Smirnakis K. Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world. Expert Opinion On Drug Safety. 1-8. PMID 37272350 DOI: 10.1080/14740338.2023.2221027 |
0.077 |
|
| 2014 |
McLaren L, Heidinger S, Dutton DJ, Tarasuk V, Campbell NR. A repeated cross-sectional study of socio-economic inequities in dietary sodium consumption among Canadian adults: implications for national sodium reduction strategies. International Journal For Equity in Health. 13: 44. PMID 24903535 DOI: 10.1186/1475-9276-13-44 |
0.077 |
|
| 2011 |
Campbell NR, Poirier L, Tremblay G, Lindsay P, Reid D, Tobe SW. Canadian Hypertension Education Program: the science supporting New 2011 CHEP recommendations with an emphasis on health advocacy and knowledge translation. The Canadian Journal of Cardiology. 27: 407-14. PMID 21641177 DOI: 10.1016/j.cjca.2011.03.004 |
0.075 |
|
| 2011 |
Campbell NR, Neal BC, MacGregor GA. Interested in developing a national programme to reduce dietary salt? Journal of Human Hypertension. 25: 705-10. PMID 21451570 DOI: 10.1038/jhh.2011.25 |
0.074 |
|
| 2015 |
Heilmann S, Ratnakumar K, Langdon E, Kansler E, Kim I, Campbell NR, Perry E, McMahon A, Kaufman C, van Rooijen E, Lee W, Iacobuzio-Donahue C, Hynes R, Zon L, Xavier J, et al. A quantitative system for studying metastasis using transparent zebrafish. Cancer Research. PMID 26282170 DOI: 10.1158/0008-5472.Can-14-3319 |
0.073 |
|
| 2012 |
Campbell NR, Dary O, Cappuccio FP, Neufeld LM, Harding KB, Zimmermann MB. Need for coordinated programs to improve global health by optimizing salt and iodine intake. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 32: 281-6. PMID 23299289 |
0.072 |
|
| 2015 |
Campbell NR, Lackland DT, Lisheng L, Zhang XH, Nilsson PM, Niebylski ML. The World Hypertension League: where now and where to in salt reduction. Cardiovascular Diagnosis and Therapy. 5: 238-42. PMID 26090335 DOI: 10.3978/J.Issn.2223-3652.2015.04.08 |
0.071 |
|
| 2022 |
Foley J, Xiong K, Hoyt T, Singh CM, Riddle E, de Moor C, Plavina T, Campbell N. Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221130949. PMID 36377744 DOI: 10.1177/13524585221130949 |
0.07 |
|
| 2012 |
Pramanik D, Campbell NR, Das S, Gupta S, Chenna V, Bisht S, Sysa-Shah P, Bedja D, Karikari C, Steenbergen C, Gabrielson KL, Maitra A, Maitra A. A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget. 3: 640-50. PMID 22791660 DOI: 10.18632/Oncotarget.543 |
0.069 |
|
| 2012 |
Gee ME, Janssen I, Pickett W, McAlister FA, Bancej CM, Joffres M, Johansen H, Campbell NR. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009. The Canadian Journal of Cardiology. 28: 367-74. PMID 22281410 DOI: 10.1016/J.Cjca.2011.08.111 |
0.068 |
|
| 2011 |
Vemula PK, Boilard E, Syed A, Campbell NR, Muluneh M, Weitz DA, Lee DM, Karp JM. On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease. Journal of Biomedical Materials Research. Part A. 97: 103-10. PMID 21404422 DOI: 10.1002/Jbm.A.33020 |
0.066 |
|
| 2011 |
Walker RL, Gee ME, Bancej C, Nolan RP, Kaczorowski J, Joffres M, Bienek A, Gwadry-Sridhar F, Campbell NR. Health behaviour advice from health professionals to Canadian adults with hypertension: results from a national survey. The Canadian Journal of Cardiology. 27: 446-54. PMID 21684718 DOI: 10.1016/J.Cjca.2011.03.013 |
0.065 |
|
| 2012 |
Gupta S, Pramanik D, Mukherjee R, Campbell NR, Elumalai S, de Wilde RF, Hong SM, Goggins MG, De Jesus-Acosta A, Laheru D, Maitra A. Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 280-9. PMID 22010213 DOI: 10.1158/1078-0432.Ccr-11-2165 |
0.063 |
|
| 2015 |
Campbell NR, Lackland DT, Niebylski ML. 2014 dietary salt fact sheet of the World Hypertension League, International Society of Hypertension, Pan American Health Organization technical advisory group on cardiovascular disease prevention through dietary salt reduction, the World Health Organization collaborating centre on population salt reduction, and World Action on Salt & Health. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 7-9. PMID 25265529 DOI: 10.1111/Jch.12402 |
0.062 |
|
| 2013 |
Hess JE, Campbell NR, Close DA, Docker MF, Narum SR. Population genomics of Pacific lamprey: adaptive variation in a highly dispersive species. Molecular Ecology. 22: 2898-916. PMID 23205767 DOI: 10.1111/Mec.12150 |
0.061 |
|
| 2014 |
Campbell NR, Niebylski ML. Prevention and control of hypertension: developing a global agenda. Current Opinion in Cardiology. 29: 324-30. PMID 25029450 DOI: 10.1097/HCO.0000000000000067 |
0.061 |
|
| 2012 |
Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong SM, Zhao M, Rudek MA, Khan SR, Rudin CM, Maitra A. A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists. Molecular Cancer Therapeutics. 11: 165-73. PMID 22027695 DOI: 10.1158/1535-7163.Mct-11-0341 |
0.06 |
|
| 2012 |
Gee ME, Bienek A, Campbell NR, Bancej CM, Robitaille C, Kaczorowski J, Joffres M, Dai S, Gwadry-Sridar F, Nolan RP. Prevalence of, and barriers to, preventive lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension). The American Journal of Cardiology. 109: 570-5. PMID 22154320 DOI: 10.1016/J.Amjcard.2011.09.051 |
0.06 |
|
| 2015 |
Blom KC, Farina S, Gomez YH, Campbell NR, Hemmelgarn BR, Cloutier L, McKay DW, Dawes M, Tobe SW, Bolli P, Gelfer M, McLean D, Bartlett G, Joseph L, Featherstone R, et al. MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): a review & study protocol. Current Hypertension Reports. 17: 533. PMID 25790798 DOI: 10.1007/S11906-015-0533-5 |
0.059 |
|
| 2011 |
Campbell NR, Willis KJ, L'Abbe M, Strang R, Young E. Canadian initiatives to prevent hypertension by reducing dietary sodium. Nutrients. 3: 756-64. PMID 22254122 DOI: 10.3390/nu3080756 |
0.059 |
|
| 2015 |
Campbell NR, Niebylski ML, Redburn K, Lisheng L, Nilsson P, Zhang XH, Lackland DT. World Hypertension League Position on Public Use of Blood Pressure Kiosks. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26387972 DOI: 10.1111/Jch.12671 |
0.055 |
|
| 2013 |
Gee ME, Pickett W, Janssen I, Johnson JA, Campbell NR. Health behaviors for hypertension management in people with and without coexisting diabetes. Journal of Clinical Hypertension (Greenwich, Conn.). 15: 389-96. PMID 23730987 DOI: 10.1111/Jch.12093 |
0.055 |
|
| 2015 |
Wielgosz A, Robinson C, Mao Y, Jiang Y, Campbell NR, Muthuri S, Morrison H. The Impact of Using Different Methods to Assess Completeness of 24-Hour Urine Collection on Estimating Dietary Sodium. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26456714 DOI: 10.1111/jch.12716 |
0.055 |
|
| 2015 |
Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, ... ... Campbell NR, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. The Canadian Journal of Cardiology. 31: 549-68. PMID 25936483 DOI: 10.1016/J.Cjca.2015.02.016 |
0.055 |
|
| 2012 |
Campbell NR, Correa-Rotter R, Legowski B, Legetic B. Efforts to reduce dietary salt in the Americas. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 32: 253-7. PMID 23299285 |
0.054 |
|
| 2014 |
Khalsa TK, Campbell NR, Lackland DT, Lisheng L, Niebylski ML, Zhang XH. A needs assessment of national hypertension organizations for hypertension prevention and control programs. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 848-55. PMID 25382563 DOI: 10.1111/Jch.12432 |
0.053 |
|
| 2012 |
Campbell NR, Johnson JA, Campbell TS. Sodium Consumption: An Individual's Choice? International Journal of Hypertension. 2012: 860954. PMID 22263106 DOI: 10.1155/2012/860954 |
0.053 |
|
| 2014 |
Walker RL, Chen G, McAlister FA, Campbell NR, Hemmelgarn BR, Dixon E, Ghali W, Rabi D, Tu K, Jette N, Quan H. Relationship between primary care physician visits and hospital/emergency use for uncomplicated hypertension, an ambulatory care-sensitive condition. The Canadian Journal of Cardiology. 30: 1640-8. PMID 25475466 DOI: 10.1016/J.Cjca.2014.09.035 |
0.052 |
|
| 2013 |
Campbell NR, McAlister FA, Quan H. Monitoring and evaluating efforts to control hypertension in Canada: why, how, and what it tells us needs to be done about current care gaps. The Canadian Journal of Cardiology. 29: 564-70. PMID 22809887 DOI: 10.1016/j.cjca.2012.05.006 |
0.051 |
|
| 2013 |
Walker RL, Chen G, McAlister FA, Campbell NR, Hemmelgarn BR, Dixon E, Ghali W, Rabi D, Tu K, Jette N, Quan H. Hospitalization for uncomplicated hypertension: an ambulatory care sensitive condition. The Canadian Journal of Cardiology. 29: 1462-9. PMID 23916738 DOI: 10.1016/J.Cjca.2013.05.002 |
0.05 |
|
| 2014 |
Gee ME, Pickett W, Janssen I, Campbell NR, Birtwhistle R. Validity of self-reported blood pressure control in people with hypertension attending a primary care center. Blood Pressure Monitoring. 19: 19-25. PMID 24356205 DOI: 10.1097/Mbp.0000000000000018 |
0.05 |
|
| 2015 |
Peng M, Chen G, Lix LM, McAlister FA, Tu K, Campbell NR, Hemmelgarn BR, Svenson LW, Quan H. Refining hypertension surveillance to account for potentially misclassified cases. Plos One. 10: e0119186. PMID 25803682 DOI: 10.1371/journal.pone.0119186 |
0.05 |
|
| 2015 |
Khalsa TK, Campbell NR, Redburn KA, Lemogoum D, Niebylski ML. A Needs Assessment of Sub-Sahara African National Hypertension Organizations for Hypertension Prevention and Control Programs. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 756-9. PMID 26212637 DOI: 10.1111/jch.12632 |
0.049 |
|
| 2014 |
Clement FM, Chen G, Khan N, Tu K, Campbell NR, Smith M, Quan H, Hemmelgarn BR, McAlister FA. Primary care physician visits by patients with incident hypertension. The Canadian Journal of Cardiology. 30: 653-60. PMID 24882537 DOI: 10.1016/j.cjca.2014.03.033 |
0.049 |
|
| 2012 |
Streppel MM, Vincent A, Mukherjee R, Campbell NR, Chen SH, Konstantopoulos K, Goggins MG, Van Seuningen I, Maitra A, Montgomery EA. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Human Pathology. 43: 1755-63. PMID 22542127 DOI: 10.1016/J.Humpath.2012.01.005 |
0.047 |
|
| 2011 |
Walker RL, Chen G, Campbell NR, McAlister FA, Quan H, Tu K, Khan NA, Hemmelgarn BR. Canadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006. The Canadian Journal of Cardiology. 27: 461-7. PMID 21640546 DOI: 10.1016/j.cjca.2010.12.071 |
0.047 |
|
| 2013 |
Quan H, Chen G, Walker RL, Wielgosz A, Dai S, Tu K, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, McAlister FA, Khan N. Incidence, cardiovascular complications and mortality of hypertension by sex and ethnicity. Heart (British Cardiac Society). 99: 715-21. PMID 23403406 DOI: 10.1136/heartjnl-2012-303152 |
0.046 |
|
| 2013 |
Bienek AS, Gee ME, Nolan RP, Kaczorowski J, Campbell NR, Bancej C, Gwadry-Sridhar F, Robitaille C, Walker RL, Dai S. Methodology of the 2009 Survey on Living with Chronic Diseases in Canada--hypertension component. Chronic Diseases and Injuries in Canada. 33: 267-76. PMID 23987223 |
0.046 |
|
| 2015 |
Ryder OS, Campbell NR, Morris HS, Forestieri S, Ruppel MJ, Cappa CD, Tivanski AV, Prather KA, Bertram TH. On the Role of Organic Coatings in Regulating N2O5 Reactive Uptake to Sea Spray Aerosol. The Journal of Physical Chemistry. A. PMID 26544641 DOI: 10.1021/Acs.Jpca.5B08892 |
0.046 |
|
| 2012 |
He FJ, Campbell NR, MacGregor GA. Reducing salt intake to prevent hypertension and cardiovascular disease. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 32: 293-300. PMID 23299291 |
0.046 |
|
| 2015 |
Campbell NR, Lackland DT, Lisheng L, Zhang XH, Nilsson PM, Redburn KA, Niebylski ML. The World Hypertension League challenges hypertension and cardiovascular organizations to develop strategic plans for the prevention and control of hypertension. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 325-7. PMID 25865341 DOI: 10.1111/jch.12557 |
0.045 |
|
| 2011 |
Campbell NR, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris SB. Hypertension in people with type 2 diabetes: Update on pharmacologic management. Canadian Family Physician Mã©Decin De Famille Canadien. 57: 997-1002, e347-53. PMID 21918140 |
0.045 |
|
| 2015 |
Tsuyuki RT, Houle SK, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NR, Cooney D, McAlister FA. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 132: 93-100. PMID 26063762 DOI: 10.1161/CIRCULATIONAHA.115.015464 |
0.044 |
|
| 2015 |
Campbell NR, Correa-Rotter R, Cappuccio FP, Webster J, Lackland DT, Neal B, MacGregor GA. Proposed nomenclature for salt intake and for reductions in dietary salt. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 247-51. PMID 25413335 DOI: 10.1111/Jch.12442 |
0.044 |
|
| 2014 |
Campbell NR, Lackland DT, Niebylski ML. High blood pressure: why prevention and control are urgent and important: a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 551-3. PMID 25040331 DOI: 10.1111/Jch.12372 |
0.044 |
|
| 2015 |
Ordunez P, Martinez R, Niebylski ML, Campbell NR. Hypertension Prevention and Control in Latin America and the Caribbean. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 499-502. PMID 25727743 DOI: 10.1111/jch.12518 |
0.043 |
|
| 2012 |
Yamanaka S, Campbell NR, An F, Kuo SC, Potter JJ, Mezey E, Maitra A, Selaru FM. Coordinated effects of microRNA-494 induce Gâ‚‚/M arrest in human cholangiocarcinoma. Cell Cycle (Georgetown, Tex.). 11: 2729-38. PMID 22785131 DOI: 10.4161/Cc.21105 |
0.043 |
|
| 2011 |
Campbell NR, Strang R, Young E. Hypertension: prevention is the next great challenge and reducing dietary sodium is the starting point. The Canadian Journal of Cardiology. 27: 434-6. PMID 21641174 DOI: 10.1016/j.cjca.2011.01.017 |
0.043 |
|
| 2015 |
Weaver CG, Clement FM, Campbell NR, James MT, Klarenbach SW, Hemmelgarn BR, Tonelli M, McBrien KA. Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study. Hypertension. PMID 26169049 DOI: 10.1161/HYPERTENSIONAHA.115.05702 |
0.042 |
|
| 2015 |
Campbell NR, Redburn KA, Niebylski ML, Drouin D, Zhang XH, Lisheng L, Nilsson P, Lackland DT. Restructuring Hypertension Congresses and Scientific Meetings for Improved Hypertension Prevention and Control. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26663751 DOI: 10.1111/Jch.12748 |
0.042 |
|
| 2012 |
Tobe SW, Poirier L, Tremblay G, Lindsay P, Reid D, Campbell NR, Khan N, Quinn RR, Rabi D. Challenges and scientific considerations in hypertension management reflected in the 2012 recommendations of the Canadian Hypertension Education Program. Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal. 6: e127-33. PMID 23687527 |
0.041 |
|
| 2015 |
Campbell NR, Lackland DT, Niebylski ML, Nilsson PM. Is reducing dietary sodium controversial? Is it the conduct of studies with flawed research methods that is controversial? A perspective from the World Hypertension League Executive Committee. Journal of Clinical Hypertension (Greenwich, Conn.). 17: 85-6. PMID 25376211 DOI: 10.1111/Jch.12437 |
0.041 |
|
| 2015 |
Hess JE, Campbell NR, Docker MF, Baker C, Jackson A, Lampman R, McIlraith B, Moser ML, Statler DP, Young WP, Wildbill AJ, Narum SR. Use of genotyping by sequencing data to develop a high-throughput and multifunctional SNP panel for conservation applications in Pacific lamprey. Molecular Ecology Resources. 15: 187-202. PMID 24842551 DOI: 10.1111/1755-0998.12283 |
0.04 |
|
| 2012 |
Gee ME, Campbell NR, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, Bienek A, Robitaille C, Joffres M, Dai S, Walker RL. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. The Canadian Journal of Cardiology. 28: 383-9. PMID 22522073 DOI: 10.1016/J.Cjca.2012.01.014 |
0.04 |
|
| 2014 |
Tu K, Anderson LN, Butt DA, Quan H, Hemmelgarn BR, Campbell NR, McAlister FA. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions. The Canadian Journal of Cardiology. 30: 647-52. PMID 24882536 DOI: 10.1016/j.cjca.2014.03.017 |
0.039 |
|
| 2014 |
Cunningham CT, Sykes LL, Metcalfe A, Cheng A, Riaz M, Lin K, Schorr E, Campbell NR, Quan H. Ethnicity and health literacy: a survey on hypertension knowledge among Canadian ethnic populations. Ethnicity & Disease. 24: 276-82. PMID 25065067 |
0.038 |
|
| 2011 |
Campbell NR, Sun B, Singh RP, Deng L. Cinchona alkaloid catalyzed enantioselective amination of α,β-unsaturated ketones: an asymmetric approach to Δ(2)-pyrazolines. Advanced Synthesis & Catalysis. 353: 3123-3128. PMID 23807876 DOI: 10.1002/Adsc.201100447 |
0.038 |
|
| 2023 |
Foley JF, Campbell N, Kong G. Extended-interval dosing of natalizumab in NOVA - Authors' reply. The Lancet. Neurology. 22: 200-201. PMID 36804085 DOI: 10.1016/S1474-4422(23)00034-0 |
0.037 |
|
| 2012 |
Campbell NR, Amish SJ, Pritchard VL, McKelvey KS, Young MK, Schwartz MK, Garza JC, Luikart G, Narum SR. Development and evaluation of 200 novel SNP assays for population genetic studies of westslope cutthroat trout and genetic identification of related taxa. Molecular Ecology Resources. 12: 942-9. PMID 22697369 DOI: 10.1111/j.1755-0998.2012.03161.x |
0.036 |
|
| 2011 |
Van Vliet BN, Campbell NR. Efforts to reduce sodium intake in Canada: why, what, and when? The Canadian Journal of Cardiology. 27: 437-45. PMID 21801976 DOI: 10.1016/j.cjca.2011.04.012 |
0.036 |
|
| 2011 |
Charrois TL, McAlister FA, Cooney D, Lewanczuk R, Kolber MR, Campbell NR, Rosenthal M, Houle SK, Tsuyuki RT. Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods. Implementation Science : Is. 6: 94. PMID 21834970 DOI: 10.1186/1748-5908-6-94 |
0.036 |
|
| 2014 |
Webster J, Land MA, Christoforou A, Eastman CJ, Zimmerman M, Campbell NR, Neal BC. Reducing dietary salt intake and preventing iodine deficiency: towards a common public health agenda. The Medical Journal of Australia. 201: 507-8. PMID 25358565 DOI: 10.5694/mja14.00818 |
0.035 |
|
| 2013 |
Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4067-78. PMID 23757351 DOI: 10.1158/1078-0432.Ccr-13-0601 |
0.035 |
|
| 2013 |
Hecht BC, Campbell NR, Holecek DE, Narum SR. Genome-wide association reveals genetic basis for the propensity to migrate in wild populations of rainbow and steelhead trout. Molecular Ecology. 22: 3061-76. PMID 23106605 DOI: 10.1111/mec.12082 |
0.035 |
|
| 2012 |
Ji C, Sykes L, Paul C, Dary O, Legetic B, Campbell NR, Cappuccio FP. Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 32: 307-15. PMID 23299293 |
0.034 |
|
| 2013 |
Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NV. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Letters. 335: 41-51. PMID 23402814 DOI: 10.1016/j.canlet.2013.01.054 |
0.034 |
|
| 2012 |
Campbell NR, Hemmelgarn BR. New recommendations for the use of ambulatory blood pressure monitoring in the diagnosis of hypertension. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 184: 633-4. PMID 22311944 DOI: 10.1503/cmaj.110501 |
0.033 |
|
| 2014 |
Weber MA, Campbell NR, Lackland DT. The journal of clinical hypertension has become the official journal of the world hypertension league. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 319. PMID 24811906 DOI: 10.1111/Jch.12338 |
0.031 |
|
| 2011 |
Bolli P, Campbell NR. Do recommendations for the management of hypertension improve cardiovascular outcome? The canadian experience. International Journal of Hypertension. 2011: 410754. PMID 22121473 DOI: 10.4061/2011/410754 |
0.03 |
|
| 2013 |
Campbell NR, Lackland DT, MacGregor GA. Dietary sodium: a perspective on recent sodium evidence--its interpretation and controversies. Journal of Clinical Hypertension (Greenwich, Conn.). 15: 765-8. PMID 24283593 DOI: 10.1111/Jch.12187 |
0.03 |
|
| 2013 |
Campbell NR, Feldman RD, Kaczorowski J, Larochelle P. High blood pressure selected as the theme for World Health Day, April 7, 2013: cup half full or half empty? The Canadian Journal of Cardiology. 29: 415-7. PMID 23454039 DOI: 10.1016/j.cjca.2013.01.014 |
0.03 |
|
| 2012 |
Campbell NR, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris S. Hypertension revisited. Canadian Family Physician Mã©Decin De Famille Canadien. 58: 634-6. PMID 22700731 |
0.029 |
|
| 2012 |
Dutton DJ, Campbell NR, Elliott C, McLaren L. A ban on marketing of foods/beverages to children: the who, why, what and how of a population health intervention. Canadian Journal of Public Health = Revue Canadienne De Santé Publique. 103: 100-2. PMID 22530530 DOI: 10.1007/Bf03404211 |
0.029 |
|
| 2013 |
Ji C, Dary O, Campbell NR, Cappuccio FP. Spot and overnight urine are inappropriate to assess population sodium intake. Revista Panamericana De Salud PãºBlica = Pan American Journal of Public Health. 34: 283. PMID 24301741 |
0.027 |
|
| 2011 |
Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Molecular Cancer Therapeutics. 10: 1470-80. PMID 21622730 DOI: 10.1158/1535-7163.Mct-11-0152 |
0.027 |
|
| 2013 |
Cappuccio FP, Neal B, Campbell NR, MacGregor GA. Salt: friend or foe? Lancet (London, England). 382: 683. PMID 23972811 DOI: 10.1016/S0140-6736(13)61775-4 |
0.027 |
|
| 2011 |
Campbell NR, Narum SR. Development of 54 novel single-nucleotide polymorphism (SNP) assays for sockeye and coho salmon and assessment of available SNPs to differentiate stocks within the Columbia River. Molecular Ecology Resources. 11: 20-30. PMID 21429160 DOI: 10.1111/j.1755-0998.2011.02977.x |
0.026 |
|
| 2015 |
Campbell NR, Bovet P, Schutte AE, Lemogoum D, Nkwescheu AS. High Blood Pressure in Sub-Saharan Africa: Why Prevention, Detection, and Control are Urgent and Important. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26073791 DOI: 10.1111/jch.12599 |
0.026 |
|
| 2014 |
Campbell NR, Berbari AE, Cloutier L, Gelfer M, Kenerson JG, Khalsa TK, Lackland DT, Lemogoum D, Mangat BK, Mohan S, Myers MG, Niebylski ML, O'Brien E, Stergiou GS, VeIga EV, et al. Policy statement of the world hypertension league on noninvasive blood pressure measurement devices and blood pressure measurement in the clinical or community setting. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 320-2. PMID 24811572 DOI: 10.1111/Jch.12336 |
0.025 |
|
| 2014 |
Niebylski ML, Lu T, Campbell NR, Arcand J, Schermel A, Hua D, Yeates KE, Tobe SW, Twohig PA, L'Abbé MR, Liu PP. Healthy food procurement policies and their impact. International Journal of Environmental Research and Public Health. 11: 2608-27. PMID 24595213 DOI: 10.3390/Ijerph110302608 |
0.024 |
|
| 2015 |
Ji C, Lu T, Dary O, Legetic B, Campbell NR, Cappuccio FP. Systematic review of studies evaluating urinary iodine concentration as a predictor of 24-hour urinary iodine excretion for estimating population iodine intake. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 38: 73-81. PMID 26506324 |
0.024 |
|
| 2015 |
Ryder OS, Campbell NR, Shaloski M, Al-Mashat H, Nathanson GM, Bertram TH. Role of Organics in Regulating ClNO₂ Production at the Air-Sea Interface. The Journal of Physical Chemistry. A. 119: 8519-26. PMID 26153795 DOI: 10.1021/Jp5129673 |
0.022 |
|
| 2015 |
Zhang XH, Lisheng L, Campbell NR, Niebylski ML, Nilsson P, Lackland DT. Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26646424 DOI: 10.1111/jch.12749 |
0.022 |
|
| 2012 |
Claro RM, Linders H, Ricardo CZ, Legetic B, Campbell NR. Consumer attitudes, knowledge, and behavior related to salt consumption in sentinel countries of the Americas. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 32: 265-73. PMID 23299287 |
0.021 |
|
| 2014 |
Houle SK, Rosenthal MM, Campbell NR, Duhaney T, Tsuyuki RT. Why pharmacists should care about the marketing of unhealthy foods: Increasing our role in public health policy / Pourquoi les pharmaciens devraient-ils s'intéresser à la promotion des aliments néfastes pour la santé? Contribuons davantage aux politiques en matière de santé publique. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 147: 4-7. PMID 24494007 DOI: 10.1177/1715163513515833 |
0.02 |
|
| 2015 |
Campbell NR, Lemogoum D. Hypertension in sub-Saharan Africa: a massive and increasing health disaster awaiting solution. Cardiovascular Journal of Africa. 26: 152-4. PMID 26407216 |
0.02 |
|
| 2013 |
Pritchard VL, Campbell NR, Narum SR, Peacock MM, Garza JC. Discovery and characterization of novel genetic markers for use in the management of Lahontan cutthroat trout (Oncorhynchus clarkii henshawi). Molecular Ecology Resources. 13: 276-88. PMID 23253773 DOI: 10.1111/1755-0998.12040 |
0.017 |
|
| 2012 |
Campbell NR, Raine KD, McLaren L. "Junk foods," "treats," or "pathogenic foods"? A call for changing nomenclature to fit the risk of today's diets. The Canadian Journal of Cardiology. 28: 403-4. PMID 22326710 DOI: 10.1016/J.Cjca.2011.11.019 |
0.016 |
|
| 2015 |
Candy JR, Campbell NR, Grinnell MH, Beacham TD, Larson WA, Narum SR. Population differentiation determined from putative neutral and divergent adaptive genetic markers in Eulachon (Thaleichthys pacificus, Osmeridae), an anadromous Pacific smelt. Molecular Ecology Resources. 15: 1421-34. PMID 25737187 DOI: 10.1111/1755-0998.12400 |
0.016 |
|
| 2012 |
Crespo NC, Elder JP, Ayala GX, Slymen DJ, Campbell NR, Sallis JF, McKenzie TL, Baquero B, Arredondo EM. Results of a multi-level intervention to prevent and control childhood obesity among Latino children: the Aventuras Para Niños Study. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 43: 84-100. PMID 22215470 DOI: 10.1007/S12160-011-9332-7 |
0.015 |
|
| 2014 |
Campbell NR, LaPatra SE, Overturf K, Towner R, Narum SR. Association mapping of disease resistance traits in rainbow trout using restriction site associated DNA sequencing. G3 (Bethesda, Md.). 4: 2473-81. PMID 25354781 DOI: 10.1534/g3.114.014621 |
0.014 |
|
| 2015 |
Campbell NR, Harmon SA, Narum SR. Genotyping-in-Thousands by sequencing (GT-seq): A cost effective SNP genotyping method based on custom amplicon sequencing. Molecular Ecology Resources. 15: 855-67. PMID 25476721 DOI: 10.1111/1755-0998.12357 |
0.013 |
|
| 2015 |
Arcand J, Webster J, Johnson C, Raj TS, Neal B, McLean R, Trieu K, Wong MM, Leung AA, Campbell NR. Announcing "Up to Date in the Science of Sodium". Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26566589 DOI: 10.1111/jch.12732 |
0.01 |
|
| 2015 |
Al Hamarneh YN, Tsuyuki RT, Campbell NR. Death by food: Why pharmacists should care. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 148: 232-3. PMID 26445578 DOI: 10.1177/1715163515596759 |
0.01 |
|
| 2015 |
Niebylski ML, Redburn KA, Duhaney T, Campbell NR. Healthy food subsidies and unhealthy food taxation: A systematic review of the evidence. Nutrition (Burbank, Los Angeles County, Calif.). 31: 787-95. PMID 25933484 DOI: 10.1016/j.nut.2014.12.010 |
0.01 |
|
| 2015 |
Narum SR, Campbell NR. Transcriptomic response to heat stress among ecologically divergent populations of redband trout. Bmc Genomics. 16: 103. PMID 25765850 DOI: 10.1186/s12864-015-1246-5 |
0.01 |
|
| 2013 |
Narum SR, Campbell NR, Meyer KA, Miller MR, Hardy RW. Thermal adaptation and acclimation of ectotherms from differing aquatic climates. Molecular Ecology. 22: 3090-7. PMID 23452191 DOI: 10.1111/mec.12240 |
0.01 |
|
| 1933 |
Campbell NR. The measurement of visual sensations Proceedings of the Physical Society. 45: 565-590. DOI: 10.1088/0959-5309/45/4/309 |
0.01 |
|
| 1920 |
Campbell NR. Electrical Discharges Journal of the RöNtgen Society. 16: 37-37. DOI: 10.1259/jrs.1920.0014 |
0.01 |
|
| Hide low-probability matches. |